Using a computational model of the human immune system, scientists have shown that efforts to combat sepsis might be more effective if they targeted multiple steps in the molecular processes that drive the illness. This finding ...
Feb 15, 2018
0
3
In an article published in the April issue of The Journal of Nuclear Medicine, researchers at Stanford University in California provide a template for assessing new positron emission tomography (PET) radiotracers that can ...
Apr 7, 2017
0
8
Depression is associated with sadness, fatigue and a lack of motivation. But people with depression can also have trouble processing information and solving problems. Now scientists studying a rat model for depression are ...
Feb 15, 2017
0
11
Research on the tiny microbes that live in our gut has yielded clues to understanding a growing number of medical conditions. A new Yale-led study explores the link between gut microbes and type 1 diabetes.
Sep 13, 2016
0
2
Diabetes heightens the risk of vascular damage to heart and limbs, and impairs the ability to repair damage with new growth of blood vessels, called angiogenesis. There are no established drugs to improve angiogenesis in ...
Aug 25, 2016
0
1
Researchers at the Yale School of Medicine and the VA Connecticut Healthcare System have successfully tailored a personalized treatment approach for chronic pain in a severe pain syndrome known as inherited erythromelalgia.
Apr 19, 2016
0
2
Researchers from the Tumour Suppression Group at the Spanish National Cancer Research Centre (CNIO), headed by Manuel Serrano, have discovered the molecular mechanisms that determine cancer predisposition in patients with ...
Oct 16, 2015
0
9
A new study from Los Angeles Biomedical Research Institute (LA BioMed) holds hope for reversing asthma caused by smoking during pregnancy.
Feb 18, 2015
0
8
(Medical Xpress)—A researcher at the University of Kentucky College of Pharmacy is working to develop the first-ever FDA-approved treatments for cocaine overdose and cocaine addiction.
Sep 18, 2014
0
0
Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the while malaria and ...
Aug 22, 2014
0
0
